6876.TWO
Price:
$17.1
Market Cap:
$554.74M
LAUNXP Biomedical Co. Ltd. is engaged in the development of medicines for tumor therapies. It also offers anti-cancer and antiproliferative drugs including virus-like nanoparticles and nanoparticles. The company was founded on September 24, 2015 and is headquartered in Taichung, Taiwan.
Industry
Biotechnology
IPO Date
2024-01-18
Stock Exchange
TWO
Ticker
6876.TWO
According to LAUNXP Biomedical Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -6.60. This represents a change of -Infinity% compared to the average of 0 of the last 4 quarters.
The mean historical PE Ratio of LAUNXP Biomedical Co., Ltd over the last ten years is -8.21. The current -6.60 PE Ratio has changed 7.94% with respect to the historical average. Over the past ten years (40 quarters), 6876.TWO's PE Ratio was at its highest in in the December 2021 quarter at 0. The PE Ratio was at its lowest in in the December 2021 quarter at 0.
Average
-8.21
Median
-8.39
Minimum
-10.87
Maximum
-6.03
Discovering the peaks and valleys of LAUNXP Biomedical Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.61%
Maximum Annual PE Ratio = -6.03
Minimum Annual Increase = -29.65%
Minimum Annual PE Ratio = -10.87
Year | PE Ratio | Change |
---|---|---|
2024 | -6.03 | -7.46% |
2023 | -6.51 | -29.65% |
2022 | -9.26 | -14.88% |
2021 | -10.87 | 29.61% |
The current PE Ratio of LAUNXP Biomedical Co., Ltd (6876.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.26
5-year avg
-8.21
10-year avg
-8.21
LAUNXP Biomedical Co., Ltd’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAUNXP Biomedical Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LAUNXP Biomedical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is LAUNXP Biomedical Co., Ltd's PE Ratio?
How is the PE Ratio calculated for LAUNXP Biomedical Co., Ltd (6876.TWO)?
What is the highest PE Ratio for LAUNXP Biomedical Co., Ltd (6876.TWO)?
What is the 3-year average PE Ratio for LAUNXP Biomedical Co., Ltd (6876.TWO)?
What is the 5-year average PE Ratio for LAUNXP Biomedical Co., Ltd (6876.TWO)?
How does the current PE Ratio for LAUNXP Biomedical Co., Ltd (6876.TWO) compare to its historical average?